View EO 12866 Meeting 0910-ZC19

Title: Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)

Agency/Subagency: 0910-HHS/FDA

Stage of Rulemaking: Notice Stage

Meeting Date/Time: 04/29/2025 10:30 AM

Requestor: King & Spalding Requestor's Name: Jeffrey Shapiro Requestor's Client: Artivion

Documents:

List of Documents

Attendees:

List of Attendees		Participation
•	Natalie Mao - NONE	Teleconference
•	Joanne Davenport - NONE	Teleconference
•	Pedro J. del Nido, MD - Chairman, Department of Cardiac Surgery, Harvard Medical	Teleconference
•	Emile A. Bacha, MD - Director, Congenital and Pediatric Cardiac Surgery, New York- Presbyterian Congenital Heart Center	Teleconference
•	Ms. Rochelle L. Maney - Vice President, Global Quality, Artivion, Inc.	Teleconference
•	Mr. Drew Green - Vice President, Regulatory Affairs, Artivion, Inc.	Teleconference
•	Ms. Jean Holloway - SVP, General Counsel, Chief Compliance Officer, Artivion, Inc.	Teleconference
•	Mr. Jeffrey K. Shapiro - King & Spalding	Teleconference